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Abstract: This study aims to elucidate the effects of chrysin on human ER-negative breast 
cancer cell line, MDA-MB-231. The study demonstrated that treatment of MDA-MB-231 
cells with 20 µ M chysin for 48 h significantly inhibited the growth of MDA-MB-231 cells 
and induced cytoplasmic lipid accumulation in the cells, but that the observed of cell death 
was  not  caused  by  apoptosis.  The  expression  of  PPARalpha  mRNA  in  chrysin-treated 
MDA-MB-231  cells  was  significantly  increased,  which  was  likely  associated  to  the 
proliferation of the cells post chrysin treatment. 
Keywords: chrysin; cell growth inhibition; lipid accumulation; apoptosis; PPAR mRNA 
expression; ER-negative breast cancer 
 
1. Introduction  
Chrysin is a natural phytochemical flavonoid belonging to the flavone group (Figure 1) which is 
ubiquitously  found  in  fruits  and  vegetables  [1,2].  Besides  giving  flavour  and  colour,  flavonoids, 
including chrysin, have recently been identified as displaying important biological roles in nitrogen 
fixation  and  chemical  defence.  Chrysin,  in  particular,  has  been  shown  to  have  a  broad  range  of 
pharmacological  effects,  including  anti-oxidation,  anti-viral  and  anti-inflammatory  properties  in  a 
OPEN ACCESS Int. J. Mol. Sci. 2010, 11                       
 
 
1058 
diverse range of human and rat cells [3,4]. Chrysin has also been observed to reduce the risk of cancer 
and other major chronic diseases [1], and has been observed to display anti-cancer properties on breast 
cancer cells, though the mechanisms have not been well established [5]. To further elucidate these 
mechanisms, our study aimed to evaluate the effects of chrysin treatment on human estrogen receptor 
(ER)-negative breast cancer cells using MDA-MB-231 cell line as a model. 
Figure 1. (A) Chrysin is in the flavones group of the flavonoids. (B) The generic structure 
of  flavone  type  of  flavonoids.  The  structure  comprises  of  ring  A,  ring  B  and  ring  C.  
(C) Chrysin has hydroxyl group at position 5, 7 in ring A [4]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MDA-MB-231  is  an  ER-negative  breast  cancer  cell  line  that  was  derived  from  a  metastatic 
adenocarcinoma on the mammary glad of a 51-year-old Caucasian woman, according to the ATCC. 
The cells are highly aggressive, invasive and poorly-differentiated [6]. It is the most commonly used 
cell line for human ER-negative breast cancer studies. The ER-negative breast cancer is specifically 
studied  due  to  a  lack  of  cellular  targets  compared  with  ER-positive  breast  cancer,  which  can  be 
effectively inhibited by targeting the estrogen receptor with anti-estrogen agents such as tamoxifen. 
The proliferation of ER-negative breast cancer cells is not affected by estrogen, which negates the use 
of anti-estrogen therapies. This makes the search for potential anti-cancer agents to treat ER-negative 
breast cancer all the more urgent and important. 
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In this study, the viability of MDA-MB-231 cells treated with different concentrations of chrysin 
and  for  different  treatment  times  was  evaluated  using  trypan  blue  assay.  Determination  of  the 
preliminary viability effect of chrysin, in this study, was sourced from previous studies described in 
Table 1 [5,7–10]. Once the effective concentration and treatment time of chrysin were determined, 
several tests were performed to discern the state of cell differentiation and the mechanisms of cell 
death. The cell differentiation in chrysin-treated MDA-MB-231 cells was performed using Oil-red O 
staining, whereas the effect of  chrysin on apoptosis was examined using DNA fragmentation and 
TUNEL assays. Finally, the expression of peroxisome proliferator-activated receptor (PPAR) alpha, 
delta and gamma mRNAs was semi-quantified using RT-PCR to identify the levels of PPAR mRNAs, 
which may potentially be affected by the chrysin treatment. This study seeks to elucidate the anti-
cancer effects and cellular mechanisms of chrysin in order to support a rational use on breast cancer 
treatment. The data obtained from this study may provide valuable information to improve treatment 
for aggressive, invasive and poorly-differentiated human ER-negative breast cancer. 
Table 1. The effects of chrysin in human and rat cell lines. Each study is denoted by the 
last name of the first author [5,7–10]. 
Study
  Cell type(s)  Concentration use  Title of study 
Parajuli et 
al. 2009 
U87-MG, U251,  
MDA-MB-231 
and PC3 cells 
40–100 µ M  In vitro anti-tumor mechanisms of 
various Scutellaria extracts and 
constituent flavonoids.  
Izuta et al. 
2008 
SH-SY5Y cells  20 µ M  Protective effects of Chinese propolis 
and its component, chrysin, against 
neuronal cell death via inhibition of 
mitochondrial-dependent apoptosis 
pathway in SH-SY5Y cells.  
Weng et al. 
2005 
Rat C6 glioma 
cells 
10–50 µ M  Chrysin induces G1 phase cell cycle 
arrest in C6 glioma cells through 
inducing p21Waf1/Cip1 expression and 
involvement of p38 mitogen-activated 
protein kinase.  
Woo et al. 
2004 
U937 
promonocytic 
cells 
10 µ M  Chrysin-induced apoptosis is mediated 
through caspase activation and Akt 
inactivation in U937 leukemia cells. 
Zhang et al. 
2004 
HeLa cells  30 µ M  Chrysin and its phosphate ester inhibit 
cell proliferation and induce apoptosis in 
Hela cells.  
2. Results and Discussion  
Figure  2A  shows  the  viability  of  MDA-MB-231  cells  treated  with  different  concentrations  of 
chrysin for 24 h and 48 h. Chrysin was observed to inhibit the growth of MDA-MB-231 cells up to  
48 h treatment in a dose-dependent manner. After 24 h treatment, the percentage of cell viability 
ranged from 92.8% to 80.9% when the MDA-MB-231 cells were treated with the lowest (5 M) to the 
highest (25 M) concentration of chrysin, respectively. However, the reduction of cell viability at all Int. J. Mol. Sci. 2010, 11                       
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concentrations at this treatment time was not statistically significant. The growth of MDA-MB-231 
cells was significantly inhibited when the cells were treated with 20 µ M of chrysin for 48 h, where the 
cell viability was reduced to 73.9% (p < 0.05). Chrysin at 25 µ M concentration exhibited a similar 
significant inhibitory effect upon the 20 µ M concentration with a reduction of cell viability to 73.1% 
(p < 0.05). Thus, 20 µ M chrysin for 48 h was used as the effective concentration and treatment time 
for subsequent cell differentiation and cell death experiments. 
Figure 2. The effect of chrysin on the growth of MDA-MB-231 cells for 24 h and 48 h 
assessed using (A) the trypan blue assay and (B) the LDH assay. The data are mean ±  SD 
of triplicate cultures. Analysis of one-way ANOVA was used to compare the viability of 
MDA-MB-231 cells in different concentrations of chrysin compared to control at each 
treatment time. p < 0.05 was regarded as statistically significant. 
(A)  Trypan Blue assay        (B)    LDH assay 
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Trypan blue, use in this study, is a fast and reliable colorimetric method to assess the cell viability. 
The assay, in which trypan blue is excluded from live cells but accumulated in dead cells, is one of the 
most commonly used methods for calculating the percentages of live and dead cells in a given cell 
population  [16].  The  trypan  blue  assay  is  also  useful  in  DNA  content  analysis ,  which  cannot  be 
analysed  by  some  other  methods,  such  as  lactate  dehydrogenase  (LDH)  release  assay  and  assay 
determine the level of tetrazolium salt (MTT). In this study, the LDH assay was performed to measure 
the growth inhibitory effect of chrysin on MDA-MB-231 cells after 48 h treatment in order to validate 
the original results of the trypan blue assay. The results of these two assays were almost identical 
(Figure 2B). 
Cell  death,  particularly  apoptotic  DNA  fragmentation  was  examined  in  chrysin -treated  
MDA-MB-231  cells  because  the  reduction  of  cell  viability  was  likely to  be  an  outcome  of 
mitochondrial dysfunction, which would eventually lead to the cell death, according to Mosmann [11]. 
However,  in  our  study,  the  cell  death  experiments  indicated  that  the  growth  of  chrysin -treated  
MDA-MB-231 cells was not inhibited through apoptosis. The apoptotic DNA fragmentation test and 
fluorescence microscopy using TUNEL assay showed no apoptotic cells were detected in the chrysin-
treated MDA-MB-231 cells (Figures 3 and 4), though cytoplasmic lipid accumulation was observed in 
the chrysin-treated MDA-MB-231 cells (Figure 5). The DNA fragmentation assay showed no cleavage Int. J. Mol. Sci. 2010, 11                       
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of chromosomal DNA into oligonucleosomal size fragments and the TUNEL staining showed no green 
DNA  break  staining,  both  of  which  are  positive  indicators  of  apoptosis.  The  high  rate  of  lipid 
accumulation in the cytoplasm of chrysin-treated MDA-MB-231 cells observed through the Oil-Red O 
staining in Figure 5 indicates that the cells may undergo cell differentiation which may be due to the 
increased expression of PPARs (lipid sensors) in the cytoplasm after chrysin treatment [14]. However, 
the lack of effect of chrysin on apoptosis in MDA-MB-231 cells is not known. Thus, the expression of 
PPAR  mRNAs  was  subsequently  determined  in  chrysin-treated  MDA-MB-231  cells  using  semi-
quantitative RT-PCR. Only mRNA expression was determined in this study because we would like to 
highlight the initial changes in the mRNA expression level which is an important indicators of the 
early events in cell regulation.  
Figure 3. Fragmentations of the genomic DNA of MDA-MB-231 cells post treatments.  
(A) DNA marker. The cells were treated with (B) 0.1% DMSO or (C) 20 µ M chrysin for 
48  h.  (D)  positive  control  provided  by  the  kit.  Fragmented  DNA  was  extracted  and 
analysed using 1% agarose gel. 
 
 
Figure 4. TUNEL staining of MDA-MB-231 cells post treatments. (A) The MDA-MB-231 
cells, treated with DNase I recombinant, showed positive staining of apoptotic nuclei. The 
MDA-MB-231 cells, treated with (B) 0.1% DMSO or (C) 20 µ M chrysin for 48 h, did not 
show the positive staining of apoptotic nuclei. 
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Figure  5.  Cytoplasmic  lipid  accumulation  post  treatments.  The  MDA-MB-231  cells, 
treated with (A) 0.1% DMSO or (B) 20 µ M chrysin for 48 h, showed cytoplasmic lipid 
accumulation in the cells. 
 
 
   
 
Following  semi-quantitative  RT-PCR,  the  gels  showed  that  single  bands  were  detected  for  the 
PPARalpha,  PPARdelta,  PPARgamma  and  GAPDH  bands  in  both  the  chrysin-treated  and  control 
DMSO-treated MDA-MB-231 cells (Figure 6A). The PCR reactions resulted in bands of 344 bp for 
PPARalpha(Lane 1-2), 566 bp for PPARdelta(Lane 3-4), 228 bp for PPARgamma(Lane 5-6) and 
137- bp for GAPDH (Lane 7-8). In Figure 6B, treatment of MDA-MB-231 cells with 20 µ M chrysin 
for 48 h showed a significant increase of the PPARalpha mRNA (p < 0.05), as reflected in the intensity 
of the band compared with the control samples (ratio intensity of PPARalpha and control samples were 
0.55 and 0.27, respectively). There was also an increase in the intensity of the PPARgamma band in 
chrysin-treated MDA-MB-231 cells but it was not statistically significant when compared with the 
control samples (ratio intensity of PPARgamma and control samples were 0.55 and 0.45, respectively). 
This phenomenon indicates that increased expression of PPARalphamRNA may directly or indirectly 
plays an important role in MDA-MB-231 cells when the cells were inhibited by chrysin treatment.  
Figure 6. (A) The PCR bands of PPARs and GAPDH in control DMSO-treated (NT) and 
chrysin-treated (T) MDA-MB-231 cells at 48 h treatment. The GAPDH gene, which was 
used as internal control, indicates an equal loading of cDNA samples. The results shown 
are representative of three independent experiments. (B) The densitometric values of the 
bands are shown as mean± SD from three independent experiments. The student’s t-test 
was  used  to  compare  the  intensity  of  the  PPARs  PCR  bands  between  (T)  and  (NT).  
p < 0.05 was regarded as statistically significant.  
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Figure 6. Cont. 
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Our  study  demonstrated  that  chrysin  inhibited  the  growth  of  MDA -MB-231  cells  in  a  dose-
dependent manner. The inhibition of cell growth was consistent with that reported by Parajuli et al. 
[5], who used chrysin extracted from the leaf, stem and roots of various Scutellaria plants. According 
to  their  study,  chrysin  at  a  concentration  of  100  M  significantly  inhibited  the  growth  of  
MDA-MB-231 cells after 4 days’ treatment (about 50.0%, p < 0.05). In our study, 20 M chrysin, at 
97% purity, was sufficient to inhibit the growth of MDA-MB-231 cells after two days’ treatment 
(73.9%,  p  <  0.05).  A  48  h  treatment  of  20  M  chrysin  was  used  to  determine  the  preliminary 
mechanisms of the chrysin on MDA-MB-231 cells, because this was the condition under which the 
induction of early growth inhibition in MDA-MB-231 cells was statistically significant (Figure 2). 
Increase  of  chrysin  concentration  did  not  increase  the  growth  inhibition  but  rather  triggered  the 
accumulation of the drug crystal in the culture. Moreover, the treatment time used in this preliminary 
study was no longer than 48 h because only these time points will be used to determine the effects of 
chrysin and ciglitazone treatment in combination on MDA-MB-231 cells in the follow-up study, in 
which a 48 h treatment of 20 µM  ciglitazone induced about 50% growth inhibition on MDA-MB-231 
cells, in contrast to its growth  inhibition of about 60% in normal breast cells. When chrysin  and 
ciglitazone were used in combination, ciglitazone was needed in a lower dose, and less cytotoxicity on 
normal breast cells was observed after 48 h treatment (data not shown).  
As 48 h is sufficient to assess the effect of chrysin on MDA-MB-231 cells, a longer treatment time 
was  not  necessary  for  our  preliminary  optimisation  study.  Indeed,  study  of  Parajuli  et  al.  (2009) 
demonstrated that chrysin at a concentration of 100 µ M significantly inhibited the proliferation of 
MDA-MB-231 cells  after 4 days treatment, but  no apoptosis was  reported  in  the study when the 
mechanism was assessed by flow cytometry, indicating that the increase of chrysin concentration and 
treatment time did not augment its effects on MDA-MB-231 cells. Moreover, although IC50 is the 
most common representative index of the dose-response curve to assess the half maximal effective 
concentration of a drug, some other endpoints, such as IC20 and IC80, are also necessary to assess the 
early inhibitory effect of a drug after certain specified exposure time. 
Our  study  also  revealed  that  the  inhibition  of  cell  growth  was  likely  influenced  by  increased 
expression of PPARalpha mRNA in the cells. Although the level of PPARgamma mRNA was not 
(B) 
PPARalpha  PPARdelta  PPARgamma Int. J. Mol. Sci. 2010, 11                       
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significantly higher in the chrysin-treated MDA-MB-231 cells, its high expression in cytoplasm was 
likely directly or indirectly associated with increased mRNA level of PPARalpha in the treated cells. 
This is similar as demonstrated by Bocca [12] that PPARgamma-mediated pathway is not apparently 
involved on the growth inhibitory activity, but it could be involved via establishing the connection 
with PPARalpha pathway. Moreover, the expression of PPARalpha was recently demonstrated to be 
associated with tumorigenesis and its mRNA is detected expressing in MCF-7 and MDA-MB-231 cell 
lines [13]. The PPARalphais predicted to regulate the cancer cell proliferation, though the role of 
PPARalpha in cellular apoptosis was not demonstrated and being studied as wide as the PPARgamma. 
In Suchanek et al. study [13], the expression of PPARalpha mRNA was regulated in MDA-MB-231 
cells and the PPARalpha activation significantly increased the proliferation of the cells. The promotion 
of cell proliferation in MDA-MB-231 and MCF-7 following the PPARalpha activation was likely in 
stark contrast to the effects of PPARgamma-activating ligands that decreased the proliferation in these 
cells, according to the study. Indeed, the PPARalpha and PPARgamma activation had very different 
effects on the breast cancer cells. Therefore, further studies are required to determine the expression of 
PPARalpha and PPARgamma mRNAs which were likely induced when the growth of MDA-MB-231 
cells was inhibited by the chrysin treatment. More data is needed to further reveal the mechanism of 
cancer cell growth inhibition mediated by the PPARalpha and PPARgamma as these transcription 
factors may play important roles as mediators when the cancer cell growth is inhibited by potential 
anti-cancer agents such as chrysin. Perhaps, the involvement of PPARalpha and PPARgamma can be 
related to AA signalling pathway which leading to an increase in cellular ceramide concentration [15]. 
Study  of  the  interaction  of  these  pathways  could  provide  useful  information  to  develop  drug 
combinations that maximise the growth inhibitory effect on ER-negative breast cancer cells. 
3. Experimental Section 
3.1. Cell Culture 
The MDA-MB-231 cell line was a kind gift from the John Hopkins Research Center. The cells were 
maintained with DMEM (Gibco BRL) supplemented with 10% (v/v) FBS (Gibco BRL), 100 U/mL 
penicillin and 100 mg/mL streptomycin (Gibco BRL). A MycoKill (1%) (PAA Laboratories Inc.) was 
added  into  the  growth  medium  to  prevent  mycoplasma  contamination.  The  growth  medium  was 
changed every 2–3 days and the cells were incubated at 37 ° C in a humidified atmosphere of 5% (v/v) 
CO2. Chrysin (97% purity, Sigma-Aldrich) was dissolved with DMSO (Sigma-Aldrich) as 10
−2 M 
stock. The drug stocks were then stored at −20 ° C and further diluted to the working concentration 
with assay medium [DMEM supplemented with only 2% (v/v) FBS and antibiotics]. 
3.2. Determination of Effective Concentration and Treatment Time 
The effect of chrysin on the growth of MDA-MB-231 cells was determined using the trypan blue 
assay. For this purpose, the MDA-MB-231 cells were seeded at a density of 1.0  10
3 cells/mL in two 
24-well  cell  culture  plates  (NUNC).  When  the  cells  of  each  well  reached  approximately  70% 
confluency, increasing concentrations of chrysin (5–25 µ M) were added and the cells were incubated 
for  24  h  and  48  h.  DMSO  (0.1%)  was  used  as  diluent  control  in  this  study.  All  control  and Int. J. Mol. Sci. 2010, 11                       
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experimental samples were cultured in triplicate. After 24 h treatment, the cells were harvested using 
trypsin/EDTA solution (Gibco BRL). The harvested cell suspension (0.9 mL) from each well was 
added with 0.1 mL of Trypan Blue Solution (Sigma-Aldrich) and was incubated at room temperature 
for 5 min. Living and dead cells were then counted using a hemocytometer and the cell viability (%) 
was calculated as below: 
Cell Viability (%) = (number of unstained cells per quadrant/total cells per quadrant)  100  (1)  
Living cells were observed excluding the dye (unstained cells) whereas dead cells took up the blue 
dye. The same method was used to calculate the viability of MDA-MB-231 cells after 48 h of chrysin 
treatment. Analysis of one-way ANOVA was used to compare the viability of MDA-MB-231 cells in 
different  concentrations  of  chrysin  treatment  with  control  DMSO  for  24  h  and  48  h.  The  lowest 
concentration at the effective treatment time which showed a significant reduction of cell viability was 
used as the effective concentration for subsequent experiments. 
3.3. Validation of Trypan Blue Assay with LDH Assay  
The trypan blue assay was validated using LDH assay where the cells were seeded at a density of 
1.0  10
3 cells/well in 24-well cell culture plates (NUNC). When the cells reached approximately 70% 
confluent,  the  cells  were  treated  with  increasing  concentrations  of  chrysin  for  48  h.  The  culture 
supernatants were then withdrawn for measurement of the LDH release using  Roche Cytotoxicity 
Detection  kit.  The  amount  of  LDH  release  in  the  culture  supernatant  was  measured  based  on 
absorbance of color generated from each sample, according to the manufacturer’s instruction. The 
absorbance was read at 492 nm against 620 nm wavelength using ELISA reader (Thermo Labsystems). 
All treatments and control samples were analyzed in triplicate. The percentage of cell viability was 
calculated  as  (Sample  value-Low  control)/  (High  control-Low  control),  where  low  control  is  the 
absorbance of cells cultured in assay medium and high control is the absorbance of cell cultured in the 
presence of 1% (v/v) Triton-X. The high control was then referred as sample with 100% LDH release.  
3.4. Treatment of MDA-MB-231 Cells with Chrysin 
After  obtaining  the  effective  concentration  and  treatment  time  for  chrysin  on  the  growth  of  
MDA-MB-231  cells,  2  groups  of  cell  cultures  (control  DMSO-treated  and  chrysin-treated)  were 
prepared in triplicate for subsequent experiments. A total of 110
4 cells/mL were seeded into 10 cm
2 
culture  dishes  for  detection  of  apoptotic  DNA  fragments  and  extraction  of  total  RNA  for  semi-
quantitative  RT-PCR.  For  detection  of  DNA  fragmentation  by  fluorescence  microscopy  (TUNEL 
assay) and examination of cytoplasmic lipid accumulation, 110
3 cells/well were seeded into 4-well 
culture slides. The cells were grown in growth medium until they were approximately 70% confluent 
and  then pre-incubated  with  assay  medium for several  hours before  treatments. Subsequently,  the 
effective concentration of chrysin or 0.1% DMSO were added to the cells, and the cells were incubated 
at  37  ° C  in  5%  (v/v)  CO2 for the selected  effective treatment time.  Following chrysin  treatment, 
samples were subjected to examination of cytoplasmic lipid accumulation, detection of apoptotic DNA 
fragments, TUNEL assay and extraction of total RNA, as described below. Int. J. Mol. Sci. 2010, 11                       
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3.5. Examination of Cytoplasmic Lipid Accumulation 
Cytoplasmic lipid accumulation in chrysin-treated and control DMSO-treated MDA-MB-231 cells 
was examined using the Oil-Red O staining. The cells grown on culture slides were fixed with Fixation 
Solution (4% paraformaldehyde in PBS, pH 7.4) before being stained with Oil-Red O solution (Sigma-
Aldrich)  at  37  ° C  for  2  h.  Samples  were  then  counter-stained  with  Mayer  hematoxylin  solution 
(Sigma-Aldrich) and mounted with aqueous mounting medium. The morphology of the stained cells 
was  examined  using  a  Nikon  eclipse  TS100  inverted  microscope  at  200×   magnification  and  the 
pictures were taken with a Nikon COLPIX digital camera.  
3.6. Detection of Apoptotic DNA Fragments 
Apoptotic DNA fragment detection in chrysin-treated and control DMSO-treated MDA-MB-231 
cells was performed using the Calbiochem Suicide Track DNA Ladder Isolation Kit, according to the 
manufacturer’s instructions. For this purpose, samples grown in culture dishes were harvested and  
re-suspended  in  the  lysis  buffer  provided  in  the  kit.  The  DNA  was  extracted  and  subjected  to 
electrophoresis on 1% agarose gels containing 0.1 μg/mL EtBr. Samples on the gel were visualized 
and photographed using the GeneSnap software on the Gene Genius Image Analyser. 
3.7. TUNEL Assay 
DNA  fragmentation  detection  of  TUNEL  in  chrysin-treated  and  control  DMSO-treated  
MDA-MB-231 cells was performed using the Roche In Situ Cell Death Detection Kit, Fluorescein, 
according to the manufacturer’s instructions. For this purpose, samples grown on culture slides were 
dried and fixed with freshly prepared Fixation Solution, as described above. Cells were then incubated 
in a Permeabilisation Solution (0.1% Triton X-100 in 0.1% sodium citrate) before being re-suspended 
in the TUNEL reaction mixture provided in the kit. Samples were mounted with aqueous mounting 
medium  and  observed  under  a  fluorescence  microscope  (Nikon  ECLIPSE  TE2000-U).  DNase  I 
recombinant was used as positive control for this assay.  
3.8. Extraction of Total RNA and cDNA Synthesis 
Extraction of total RNA from chrysin-treated and control DMSO-treated MDA-MB-231 cells was 
performed  using  the  TRI  Reagent  (Molecular  Research  Center),  according  to  the  manufacturer’s 
instructions. The integrity of total RNA extracted was confirmed using agarose gel electrophoresis, 
whilst purity and yield were measured using an Eppendorf spectrophotometer. Subsequently, 1 μg of 
total RNA per sample was reverse transcribed to cDNA using the Fermentas RevertAid™ H Minus 
First Strand cDNA Synthesis Kit, according to the manufacturer’s instructions. The success of cDNA 
synthesis was validated with PCR amplification using human GAPDH housekeeping gene.  
3.9. Quantitation of Gene Expression at mRNA Level 
Following cDNA synthesis, levels of PPAR mRNAs in chrysin-treated and control MDA-MB-231 
cells were semi-quantified using PCR and gel densitometry. The levels of mRNAs were expressed as Int. J. Mol. Sci. 2010, 11                       
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the band intensity of PPAR PCR products relative to the control GAPDH PCR product. The student’s 
t-test  was  used  to  compare  the  expression  of  PPAR  mRNAs  between  chrysin-treated  and  control 
DMSO-treated cells. The primers used for the PCR reactions are detailed in Table 2. PCR reactions 
were performed in a total volume of 25 L consisting of 2.0 µL of cDNA, 0.3 µL of 10 mM dNTP 
Mix, 2.0 µL of 25 mM MgCl2, 2.0 µ L of 10 Taq Buffer with (NH4)2SO4, 0.2 µL of Taq DNA 
Polymerase, 1.0 µL of each 20 pmol forward and reverse primers and DNase/RNase-free water. Each 
PCR reaction was carried out in triplicate and the reaction conditions were set as below for 35 cycles:  
Pre-amplification: 94 C for 2 min 
Denaturation: 94 C for 45 s 
Annealing: 60 C for 30 s 
Elongation: 55 C for 30 s 
Extension: 72 C for 1 min  
Termination: 73 C for 10 min 
The  PCR  products  were  subjected  to  electrophoresis  on  a  0.8%  (w/v)  agarose  gel  containing 
0.1 μg/mL EtBr. Bands of PCR product on the gel were visualized and photographed using the Gene 
Genius  Image  Analyser,  and  the  band  intensity  was  analysed  using  the  LabImage  1D  2006 
Professional software (KAPELAN Bio-Imaging Solution).  
Table 2. List of primers used for semi-quantitative RT-PCR. The primers were designed 
with an annealing temperature of 60 C. 
Gene  Primer sequence  Product length 
PPARalpha 
Forward: 5’-GCCAGTATTGTCGATTTCACAAGT-3’ 
344 bp 
Reverse: 5’-CTCCTTGTTCTGGATGCCATT-3’ 
PPARdelta 
Forward: 5’-CTGCTCACCAACAGATGAAGAC-3’ 
566 bp 
Reverse: 5’-ATAGCGTTGTGTGACATGCC-3’ 
PPARgamma 
Forward: 5’-CTTTATGGAGCCCAAGTTTGAG-3’ 
228 bp 
Reverse: 5’-GCTTCACATTCAGCAAACCTG-3’ 
GAPDH 
Forward: 5’-ACAGCCTCAAGATCATCAGCA-3’ 
137 bp 
Reverse: 5’-AGTCTTCTGGGTGGCAGTGAT-3’ 
3.10. Statistical Analysis 
All  graph  drawing  and  statistical  calculations  were  performed  using  GraphPad  software.  The 
experiments were repeated several times to confirm the reproducibility of the results. All values are 
expressed as mean ±  SD. A p value of less than 0.05 was regarded as statistically significant. 
4. Conclusions 
This study identified chrysin to be a potential inhibitor on the growth of MDA-MB-231 cell line. 
Our study, for the first time, provides mechanistic evidence that chrysin treatment inhibits the growth 
of MDA-MB-231 cells and results directly or indirectly in increased expression of PPARalpha mRNA. 
However, further studies are required to investigate the role of PPARalpha in the death mechanism of Int. J. Mol. Sci. 2010, 11                       
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these  cancer  cells  induced  following  chrysin  treatment.  Such  studies  would  help  to  address  the 
hypothesis for developing effective chrysin-based for human ER-negative breast cancer treatments. 
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